Concepedia

Publication | Open Access

Silencing of NLRP3 Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin

DOIFull Paper Access

12

Citations

15

References

2023

Year

Weijia Li, Xibo Zhao, Rujian Zhang, Jiabin Xie, Guangmei Zhang
Mediators of Inflammation

Abstract

NLRP3 was overexpressed in DDP-resistant ovarian cancer. NLRP3 knockdown hindered the malignant process of DDP-resistant ovarian cancer cells, providing a potential target for DPP-based ovarian cancer chemotherapy.

References

YearCitations

Page 1